Neuca Clinical Trials Investments sp. z o.o.

Other financial service activities, except insurance and pension funding not elsewhere

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-08-02
Share capital
86,160,000.00 PLN
Registered address
ul. Forteczna 35-37, 87-100 Toruń, Poland
Website
Opening hours
Mon–Fri, 8:00–16:00
Email
Phone
Social media
Electronic delivery address
AE:PL-74311-52777-ERBUG-22

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$78,771
Profit allocationRetained in reserve capital
Deferred tax liability$5,064
Related parties2 items
Parent companyNeuca S.A.
Shares in other companies

Filing timeliness

Financial statements were filed on time, on average 84 days early.

  • 202531/03/2026
  • 202402/04/2025
  • 202311/04/2024
  • 202221/06/2023
  • 202128/06/2022
  • 202011/05/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 12%
Sector · Real estate activities1,167 / 6,219
Top 19%
City · Toruń501 / 2,418
Top 21%
Voivodeship · Kujawsko-Pomorskie2,753 / 11,442
Top 24%
Country · Poland65,324 / 297,266
Top 22%

Results vs industry

Revenue
This companyUSD 1.80mMedianUSD 77.17kAverageUSD 1.58m
Net profit
This companyUSD 1.72mMedianUSD 1.91kAverageUSD 202.79k
Operating costs
This companyUSD 8.83kMedianUSD 43.34kAverageUSD 952.74k
Assets
This companyUSD 23.38mMedianUSD 197.01kAverageUSD 10.26m

Website technology

Analytics and marketing
  • Google Tag Manager

Authorized Representatives

Aleksandra Puskarz-Kusa age 56 – Attorney-in-fact (joint)
Andrzej Zieliński age 52 – Attorney-in-fact (joint)
Tomasz Artur Grendysz age 49 – Management Board Member
Tomasz Dobrański age 55 – President of the Management Board

Manner of representation

In the case of a one-person management board, joint action by a member of the management board together with a commercial proxy is required to submit declarations of will and sign documents on behalf of the company. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to submit declarations of will and sign documents on behalf of the company.

Ownership

OwnerSharesShare valueStake
8,616$23,273,906.00100%

Beneficial owners

Person

Subsidiaries

NameStake
100%

Bank accounts

Registered as a VAT taxpayer on 2020-05-31.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Farmepo sp. z o.o.
Clinchoice sp. z o.o.
Captor Therapeutics S.A.
Medict Institute Opinie Lekarskie Orzeczenia sp. z o.o.
Aslab Science P.S.A.
Pikralida sp. z o.o.
Bioresearch Group sp. z o.o.
Silmedic sp. z o.o.
Scientia Cro sp. z o.o.
Globe Badania Kliniczne sp. z o.o.

Change history

DateEvent
2020-04-07Address change
2020-03-13Name change
2011-11-04Share capital increase
2011-06-13Name change
2010-12-02Address change

FAQ

Last updated: 2026-10-07